ORIC Pharmaceuticals, Inc.ORICNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-126.74M
↓ 96% below average
Average (7y)
$-64.51M
Historical baseline
Range
High:$-20.46M
Low:$-126.74M
CAGR
+29.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-126.74M | -15.5% |
| 2023 | $-109.75M | -27.9% |
| 2022 | $-85.80M | -10.0% |
| 2021 | $-77.97M | -61.2% |
| 2020 | $-48.37M | -86.9% |
| 2019 | $-25.88M | -26.5% |
| 2018 | $-20.46M | +3.2% |
| 2017 | $-21.13M | - |